These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7508752)

  • 21. Clinically significant drug interactions with new immunosuppressive agents.
    Mignat C
    Drug Saf; 1997 Apr; 16(4):267-78. PubMed ID: 9113494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance pharmacological immunosuppressive strategies in renal transplantation.
    Vella JP; Sayegh MH
    Postgrad Med J; 1997 Jul; 73(861):386-90. PubMed ID: 9338020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New horizons in immunosuppression.
    Simmons RL; Wang SC
    Transplant Proc; 1991 Aug; 23(4):2152-6. PubMed ID: 1714645
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin.
    Heidt S; Roelen DL; Eijsink C; van Kooten C; Claas FH; Mulder A
    Transplantation; 2008 Nov; 86(9):1292-300. PubMed ID: 19005412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.
    Hoogduijn MJ; Crop MJ; Korevaar SS; Peeters AM; Eijken M; Maat LP; Balk AH; Weimar W; Baan CC
    Transplantation; 2008 Nov; 86(9):1283-91. PubMed ID: 19005411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressive regimens of tomorrow.
    Groth CG
    Transplant Proc; 1995 Dec; 27(6):2971-3. PubMed ID: 8539797
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium.
    Lemster B; Woo J; Strednak J; Wang SC; Todo S; Starzl TE; Thomson AW
    Transplant Proc; 1992 Dec; 24(6):2845-6. PubMed ID: 1281576
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival.
    Wang J; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):699-702. PubMed ID: 1990655
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunoregulatory drugs: mechanistic basis for use in organ transplantation.
    Suthanthiran M; Strom TB
    Pediatr Nephrol; 1997 Oct; 11(5):651-7. PubMed ID: 9323301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamics of immunosuppressive drugs.
    Dambrin C; Klupp J; Morris RE
    Curr Opin Immunol; 2000 Oct; 12(5):557-62. PubMed ID: 11007359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppressive approaches to the prevention of graft vascular disease.
    Gregory CR
    Transplant Proc; 1998 May; 30(3):878-80. PubMed ID: 9595134
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and experimental immunosuppression.
    Castillo Lugo JA
    Bol Asoc Med P R; 1995; 87(5-6):106-8. PubMed ID: 8573248
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunosuppression in cardiac transplantation: a new era in immunopharmacology.
    Nair RV; Morris RE
    Curr Opin Cardiol; 1995 Mar; 10(2):207-17. PubMed ID: 7787287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive drugs: the first 50 years and a glance forward.
    Allison AC
    Immunopharmacology; 2000 May; 47(2-3):63-83. PubMed ID: 10878284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressants: cellular and molecular mechanisms of action.
    Suthanthiran M; Morris RE; Strom TB
    Am J Kidney Dis; 1996 Aug; 28(2):159-72. PubMed ID: 8768909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
    Dayton JS; Turka LA; Thompson CB; Mitchell BS
    Mol Pharmacol; 1992 Apr; 41(4):671-6. PubMed ID: 1569921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of various immunosuppressive drugs in preventing pig-to-rat islet xenograft rejection.
    Wennberg L; Wallgren AC; Karlsson-Parra A; Kozlowski T; Sundberg B; Tibell A; Groth CG; Korsgren O
    Transplant Proc; 1995 Feb; 27(1):266-7. PubMed ID: 7533391
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunosuppressive therapy in children.
    Prasad R; Singh UK; Mittal R; Mishra OP
    J Indian Med Assoc; 2011 Feb; 109(2):101-2, 104-7. PubMed ID: 21888174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutritional and intestinal effects of the novel immunosuppressive agents: deoxyspergualin, rapamycin, and mycophenolate mofetil.
    Yanchar NL; Fedorak RN; Kneteman NM; Sigalet DL
    Clin Biochem; 1996 Aug; 29(4):363-9. PubMed ID: 8828967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward the definition of immunosuppressive regimens with antitumor activity.
    Casadio F; Croci S; D'Errico Grigioni A; Corti B; Grigioni WF; Landuzzi L; Lollini PL
    Transplant Proc; 2005 Jun; 37(5):2144-7. PubMed ID: 15964362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.